Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome
MYPI2025003243A0Undetermined Publication Date: 2021-12-05NOEMA PHARMA AG
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025003243
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-03-12
- Filing Date
- 2021-06-04
- Publication Date
- 2021-12-05
Abstract
Provided herein are methods of treating Tourette Syndrome in a subject in need thereof by administering to the subject compositions comprising a PDE10 inhibitor of Formula (I). Also disclosed are crystalline solid forms of the compound of Formula (I) and uses thereof. (FORMULA 1) (NO SUITABLE FIGURE)
Need to check novelty before this filing date? Find Prior Art
